Restrictive cardiomyopathy is one of the rarest and most challenging heart muscle conditions that can affect children. Because its symptoms can resemble those of asthma, respiratory infections, or simple fatigue, it is often not recognised early. Yet early diagnosis and specialist management make a genuine difference to outcomes.
In this page Dr. Giardini This page explains what restrictive cardiomyopathy is, how it presents, how it is diagnosed, and what treatment and follow-up involve.
What Is Restrictive Cardiomyopathy?
Restrictive cardiomyopathy (RCM) is a disease of the heart muscle in which the walls of the ventricles (the heart’s lower pumping chambers) become abnormally stiff and rigid. This stiffness does not weaken the heart’s ability to squeeze and pump blood, at least not initially. The problem lies in the heart’s ability to relax and fill with blood between beats.
In a healthy heart, the ventricles expand and fill easily during the resting phase of each heartbeat. In restrictive cardiomyopathy, the stiff walls resist this expansion. Only a small amount of blood fills the ventricle before pressure inside rises sharply. This pressure backs up into the upper chambers of the heart (the atria), causing them to enlarge, and eventually into the lungs and body.
The result is diastolic heart failure: the heart cannot fill properly, even though it may initially pump normally. Over time, this impaired filling leads to breathlessness, fatigue, and eventually to more serious complications.
Restrictive cardiomyopathy represents two to five per cent of all childhood cardiomyopathies, making it the least common type. It is rare in absolute terms, and its rarity means that specialist experience matters greatly in managing it well.
How Is Restrictive Cardiomyopathy Different from Other Heart Muscle Conditions?
Understanding how RCM differs from other cardiomyopathies helps parents make sense of what they are told.
In hypertrophic cardiomyopathy (HCM), the heart muscle thickens and the heart wall becomes abnormally large. In dilated cardiomyopathy, the heart enlarges and its pumping weakens. In restrictive cardiomyopathy, the heart muscle is often normal in size and pumping strength, at least in the early stages. The abnormality lies in the stiffness of the muscle and the resulting failure to fill.
This distinction matters clinically, because the initial echocardiogram may look less dramatically abnormal than parents expect for such a serious condition. The key finding on echo in RCM is enlargement of the atria (the upper chambers), which reflects the chronically high filling pressures. The ventricles themselves may appear close to normal in size and function, particularly early in the disease. This subtlety is one of the reasons RCM is sometimes missed or misattributed to respiratory conditions in the early stages.
What Causes Restrictive Cardiomyopathy in Children?
In many children, no underlying cause is found, and the condition is termed idiopathic restrictive cardiomyopathy. Idiopathic RCM carries the most serious prognosis among childhood RCM subtypes and tends to progress more rapidly.
In other children, the restrictive physiology results from an identifiable cause. These secondary forms sometimes carry a better outlook if the underlying condition is treatable.
Genetic causes account for a significant proportion of childhood RCM. Mutations in the same sarcomere protein genes that cause hypertrophic cardiomyopathy (particularly genes encoding troponin I, troponin T, and myosin heavy chain) can produce a restrictive phenotype in children. Mutations in genes encoding desmin and filamin C are also recognised causes. Identifying a genetic cause matters because it informs family screening, guides prognosis, and may influence management decisions.
Infiltrative conditions, in which abnormal material deposits in the heart muscle, can produce restrictive cardiomyopathy. In adults, amyloidosis is the most common infiltrative cause. In children, storage disorders (such as Fabry disease, Gaucher disease, and glycogen storage disorders) and hypereosinophilic syndrome can produce a similar picture. These conditions affect other organs as well as the heart, and recognising them opens the door to disease-specific treatment.
Cardiotoxicity from chemotherapy or radiotherapy is a recognised secondary cause in children who have undergone cancer treatment. Anthracycline chemotherapy (used for leukaemia and solid tumours) can damage the heart muscle in a pattern that eventually produces restrictive physiology. This may appear years after treatment ends, which is why long-term cardiac surveillance forms part of the follow-up for childhood cancer survivors.
When Does Restrictive Cardiomyopathy Usually Appear?
Restrictive cardiomyopathy can occur at any age in childhood, but most children receive a diagnosis between the ages of five and ten years. Younger children and teenagers are also affected. Some children have subtle or no symptoms for a prolonged period before the diagnosis becomes apparent, which is part of why the condition is often diagnosed later than it develops.
What Are the Symptoms of Restrictive Cardiomyopathy?
Symptoms vary between children and often develop gradually. Many parents look back and recognise warning signs that seemed unremarkable at the time. The condition is frequently misattributed to asthma, recurrent respiratory infections, or general fatigue before the cardiac origin becomes clear.
Common symptoms include breathlessness, particularly on exertion, that may progress to breathlessness at rest in more advanced disease. Children often show reduced exercise tolerance and an inability to keep pace with their peers in physical activities. Unusual tiredness or poor stamina is frequently reported by parents before formal diagnosis. Chest discomfort, palpitations, dizziness, and fainting episodes can all occur, reflecting the combined effects of abnormal heart filling, elevated pressures, and arrhythmias.
In more advanced cases, fluid retention produces visible swelling of the abdomen or legs, reflecting high pressure backing up into the body circulation. Some children develop a persistent cough or recurrent chest infections, because fluid builds up in the lungs.
A particularly important and sometimes underappreciated complication is thromboembolism. The enlarged, high-pressure atria are prone to blood clot formation, and clots can travel to the brain (causing stroke) or to other organs. In some children, a thromboembolic event is actually the first recognised sign of the underlying cardiomyopathy. This is one of the reasons anticoagulation forms part of the management strategy in many children with RCM.
Sudden cardiac arrest, caused by a dangerous arrhythmia, is the most serious acute complication of RCM. In some children, this is the first clinical presentation. This risk underlies the importance of arrhythmia surveillance and, in selected children, implantable cardioverter-defibrillator (ICD) placement.
How Is Restrictive Cardiomyopathy Diagnosed?
Diagnosis requires a combination of investigations, and because RCM is rare, specialist experience in interpreting these investigations together is essential.
Echocardiogram
The echocardiogram is the cornerstone of diagnosis. The key findings are enlarged atria with ventricles that may appear near-normal in size, combined with a distinctive pattern of abnormal filling on Doppler analysis. The ventricles fill rapidly with a sharp rise in pressure and then stop, a pattern that distinguishes RCM from other conditions. The ventricular walls may appear normal in thickness, unlike in HCM.
Electrocardiogram (ECG)
ECG abnormalities are nearly universal in RCM. The ECG typically shows atrial enlargement, and may show ventricular hypertrophy patterns, ST segment changes, and conduction abnormalities. A normal ECG would be unusual and should prompt reconsideration of the diagnosis.
Holter Monitoring
Ambulatory heart rhythm monitoring over 24 to 48 hours (Holter monitoring) assesses for arrhythmias, particularly atrial arrhythmias, which are common in RCM. Detecting arrhythmias influences management decisions, including the need for antiarrhythmic medication or anticoagulation.
Cardiac MRI
Cardiac MRI provides detailed tissue characterisation of the heart muscle and helps distinguish RCM from constrictive pericarditis (a condition that can mimic RCM clinically but is treatable surgically). MRI also identifies infiltrative changes, fibrosis, and inflammation that may point to a specific underlying cause.
Cardiac Catheterisation
Cardiac catheterisation, in which a fine tube measures pressures directly inside the heart chambers, sometimes helps confirm the diagnosis and distinguishes RCM from constrictive pericarditis with greater certainty than non-invasive tests alone. It also assesses pulmonary arterial pressures, which is important for transplant evaluation.
Blood Tests and Metabolic Screening
Blood tests can identify metabolic storage disorders, haematological conditions, and inflammatory causes. In children with possible secondary RCM, metabolic and genetic screening forms a critical part of the diagnostic workup.
Genetic Testing
Genetic testing is appropriate for most children with RCM and their families. Identifying a causative mutation guides screening of parents and siblings, informs prognosis, and is increasingly relevant as genotype-specific management strategies develop. Dr. Giardini’s practice integrates genetic assessment as a core component of the evaluation.
How Is Restrictive Cardiomyopathy Treated?
There is currently no treatment that reverses the stiffness of the heart muscle in RCM. Management focuses on relieving symptoms, preventing complications, managing arrhythmias, reducing thromboembolism risk, and planning for advanced therapy when needed.
Heart Failure Management
Diuretics reduce fluid congestion and improve breathlessness. The balance between giving enough diuresis to relieve symptoms and avoiding over-diuresis (which reduces filling further and worsens cardiac output) is delicate and requires specialist experience. Children with RCM need careful dose titration and close monitoring.
Anticoagulation
Given the significant risk of blood clot formation in the enlarged atria and the documented risk of stroke in children with RCM, anticoagulation with warfarin or direct oral anticoagulants forms part of management for many children. This prevents clot formation and reduces the risk of embolic events.
Arrhythmia Management
Arrhythmias, particularly atrial arrhythmias, are common and require active monitoring and treatment. Antiarrhythmic medications help control rhythm in some children. For children at high risk of sudden cardiac arrest, an ICD (implantable cardioverter-defibrillator) provides protection by detecting and terminating life-threatening ventricular arrhythmias.
Activity Guidance
Physical activity guidance needs individual tailoring. Many children with RCM should avoid competitive sport and high-intensity exercise. The priority is safety: children should never push through symptoms. That said, gentle activity within comfortable limits supports physical and emotional wellbeing, and the focus should be on what a child can do, not only on restrictions.
Heart Transplantation
For children with progressive RCM that does not respond adequately to medical management, heart transplantation offers the only definitive treatment. Identifying when to list a child for transplantation is one of the most important and sensitive decisions in managing this condition. Timing matters: listing too early carries unnecessary risk, while waiting too long risks the development of irreversible pulmonary hypertension, which may preclude transplant eligibility. A cardiac transplant team experienced in paediatric RCM assesses each child individually.
What Is the Long-Term Outlook?
Honesty is important here, and families deserve a clear picture. Restrictive cardiomyopathy carries the most serious prognosis among childhood cardiomyopathies. Without heart transplantation, the outlook for idiopathic childhood RCM is poor, with a high proportion of children experiencing significant deterioration within five years of diagnosis.
With heart transplantation, outcomes have improved substantially. Transplant survival at five and ten years after cardiac transplantation in children is now considerably better than outcomes with medical therapy alone. This is why specialist centres do not delay transplant evaluation in children with confirmed idiopathic RCM.
For children with secondary RCM where a treatable underlying cause exists, identifying and treating that cause can stabilise or improve cardiac function, offering a meaningfully different trajectory.
These statistics can feel frightening, and it is important for parents to know that prognosis varies considerably between individual children and that modern management, including transplantation, has genuinely changed what is possible. Children who receive timely transplantation go on to lead active lives. The goal of specialist follow-up is to navigate each child’s unique course carefully, making the right decisions at the right time.
When Should You Seek Specialist Advice?
Any child with unexplained breathlessness, reduced exercise tolerance, recurrent chest infections that do not respond normally to treatment, chest pain, palpitations, or fainting warrants cardiac assessment. A family history of cardiomyopathy, sudden unexplained death in a young relative, or known sarcomere gene mutations should also prompt cardiac screening of children in the family.
If your child has already received a diagnosis of restrictive cardiomyopathy, specialist input from a centre experienced in paediatric cardiomyopathy is essential. Management decisions in RCM, from anticoagulation to arrhythmia management to transplant timing, benefit from specialist expertise.
Frequently Asked Questions
Is restrictive cardiomyopathy curable?
There is currently no medication or procedure that reverses the stiffness of the heart muscle in RCM. For children with secondary RCM, treating the underlying cause can stabilise the condition. Heart transplantation offers the best long-term outcome for children with idiopathic RCM that progresses despite medical management, and transplant recipients go on to lead active lives.
How serious is restrictive cardiomyopathy in children?
Idiopathic RCM is the most serious of the childhood cardiomyopathies in terms of prognosis. This does not mean every child faces the same trajectory. Some children remain relatively stable for years, while others progress more rapidly. The key is early diagnosis, expert management, and timely planning for transplantation when appropriate.
Can my child attend school and live a normal life?
Many children with RCM attend school normally and participate in everyday activities. Competitive sport and high-intensity exercise are generally not advisable, but gentle, self-paced activity is usually appropriate. The specific guidance depends on the individual child’s condition and should come from their cardiomyopathy specialist.
Is restrictive cardiomyopathy inherited?
In some cases, yes. Mutations in sarcomere genes (the same gene families that cause HCM) can produce RCM in children. Genetic testing forms part of the standard assessment. When a genetic cause is found, parents and siblings have a meaningful chance of carrying the same mutation and should undergo cardiac screening.
Can restrictive cardiomyopathy be mistaken for asthma?
Yes, and this is well recognised. Breathlessness, exercise intolerance, and recurrent chest symptoms can all mimic asthma or respiratory infections. Children with RCM often receive one of these diagnoses before the cardiac origin becomes clear. Any child whose respiratory symptoms do not respond normally to treatment, or who has other features such as poor stamina or an abnormal heart sound, warrants cardiac evaluation.
What tests does my child need?
The core investigations include an echocardiogram, ECG, and Holter monitor. Cardiac MRI adds important detail, particularly in distinguishing RCM from constrictive pericarditis and in identifying infiltrative causes. Cardiac catheterisation provides pressure measurements when needed. Blood tests, metabolic screening, and genetic testing complete the workup.
Will my child need a heart transplant?
Some children with idiopathic RCM will eventually need heart transplantation. Many children remain stable for a number of years. The decision about transplant listing requires careful, expert assessment of disease progression, pulmonary artery pressures, and overall clinical trajectory. Early referral to a specialist centre allows this assessment to happen at the right time.
Does my child need lifelong follow-up?
Yes, absolutely. Even children who are stable require regular specialist monitoring, including echocardiography, heart rhythm assessment, and evaluation of pulmonary pressures. Follow-up allows management to adapt as the condition evolves and ensures transplant planning happens when needed, not after the optimal window has passed.
What is the risk of sudden cardiac arrest in children with RCM?
Sudden cardiac arrest is a recognised risk in RCM, caused by dangerous arrhythmias. For children identified to be at higher risk, an ICD (implantable cardioverter-defibrillator) offers protection. The decision about ICD placement requires individual risk assessment by a specialist with experience in paediatric cardiomyopathy.
When should I seek a second opinion?
A second opinion is worthwhile when the diagnosis is uncertain, when a management plan involves major decisions (such as anticoagulation, ICD implantation, or transplant listing), or simply when parents want independent reassurance from a specialist experienced in paediatric cardiomyopathy.
Author: Dr. Alessandro Giardini, MD, PhD
Written 13/04/2026